{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:04:12Z","timestamp":1792173852099,"version":"4.4.0"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,12,15]]},"DOI":"10.2169\/internalmedicine.3488-24","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T22:12:09Z","timestamp":1715206329000},"page":"3339-3344","source":"Crossref","is-referenced-by-count":2,"title":["Type 1 Diabetes Mellitus with Diabetic Ketoacidosis Presenting with Transient Severe Fatty Liver and Subsequent Liver Dysfunction"],"prefix":"10.2169","volume":"63","author":[{"given":"Takayuki","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Orime","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Akamatsu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Terauchi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metabolism 63: 895-902, 2014.","DOI":"10.1016\/j.metabol.2014.04.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tietge UJ, Bakillah A, Maugeais C, Tsukamoto K, Hussain M, Rader DJ. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res 40: 2134-2139, 1999.","DOI":"10.1016\/S0022-2275(20)32437-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140, 2016.","DOI":"10.1126\/science.1128294"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Atmaca M, Ucler R, Kartal M, et al. Glycogenic hepatopathy in type 1 diabetes mellitus. Case Reports Hepatol 2015: 236143, 2015.","DOI":"10.1155\/2015\/236143"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Asada S, Kawaratani H, Mashitani T, et al. Glycogenic hepatopathy in type 1 diabetes mellitus. Intern Med 57: 1087-1092, 2018.","DOI":"10.2169\/internalmedicine.9490-17"},{"key":"6","unstructured":"6. Garc\u00eda-Su\u00e1rez C, \u00c1lvarez Su\u00e1rez B, Castro Ortiz E, et al. Glycogenic hepatopathy: a rare and reversible cause of elevated transaminases in diabetic patients. Case report. Rev Esp Enferm Dig 107: 111-112, 2015."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Alenazy LA, Javed M, Elsiesy H, Raddaoui E, Al-Hamoudi WK. Glycogenic hepatopathy: a rare hepatic complication of poorly controlled type 1 DM. Case Rep Med 2020: 1294074, 2020.","DOI":"10.1155\/2020\/1294074"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takaike H, Uchigata Y, Iwamoto Y, et al. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus. Ann Med 40: 395-400, 2008.","DOI":"10.1080\/07853890802032711"},{"key":"9","unstructured":"9. Nagao H, Okada T, Suzuki A, Terakawa H, Fujita S, Tsugawa M. A case of fulminant type 1 diabetes mellitus with transient hepatic dysfunction, hepatic steatosis and pancreatic enlargement. J Jpn Diab Soc 55: 722-726, 2012 (in Japanese)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tamura S, Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 115: 1139-1142, 2015.","DOI":"10.1172\/JCI24930"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine (Baltimore) 75: 327-333, 1996.","DOI":"10.1097\/00005792-199611000-00003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sherigar JM, Castro J, Yin YM, Guss D, Mohanty SR. Glycogenic hepatopathy: a narrative review. World J Hepatol 10: 172-185, 2018.","DOI":"10.4254\/wjh.v10.i2.172"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shah ND, Sasatomi E, Baron TH. Acute and relapsing hepatitis caused by glycogenic hepatopathy. Clin Gastroenterol Hepatol 15: 23-24, 2017.","DOI":"10.1016\/j.cgh.2017.02.004"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Brown D, Mead T. A case report of glycogenic hepatopathy. J Educ Teach Emerg Med 6: V1-V3, 2021.","DOI":"10.5070\/M56354258"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sharma B, Antoine M, Shah M, Nagamos RN, John S. Glycogenic hepatopathy. ACG Case Rep J 6: 1-3, 2019.","DOI":"10.14309\/crj.0000000000000115"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Plaza Enriquez L, Konindala N, Yeh H, Khatiwada P, Sanchez Valenzuela M, Askari K. A case report about glycogenic hepatopathy. Case Rep Endocrinol 2022: 5134049, 2022.","DOI":"10.1155\/2022\/5134049"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Abboud W, Abdulla S, Al Zaabi M, Moufarrej R. Young man with hepatomegaly: a case of glycogenic hepatopathy. Case Reports Hepatol 2018: 6037530, 2018.","DOI":"10.1155\/2018\/6037530"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Deemer KS, Alvarez GF. A rare case of persistent lactic acidosis in the ICU: glycogenic hepatopathy and Mauriac syndrome. Case Rep Crit Care 2016: 6072909, 2016.","DOI":"10.1155\/2016\/6072909"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Munugoti S, Reddy V, Patel G, Gaddem M, Abburi T. A case of glycogenic hepatopathy as a complication of poorly controlled type 1 diabetes mellitus. Case Rep Endocrinol 2022: 8939867, 2022.","DOI":"10.1155\/2022\/8939867"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Adams SH, Bernshteyn M, Masood U, Corines J, Manocha D. Glycogenic hepatopathy masquerading as acute pancreatitis. Cureus 13: e13397, 2021.","DOI":"10.7759\/cureus.13397"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Satyarengga M, Zubatov Y, Frances S, Narayanswami G, Galindo RJ. Glycogenic hepatopathy: a complication of uncontrolled diabetes. AACE Clin Case Rep 3: e255-e259, 2017.","DOI":"10.4158\/EP161483.CR"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yousaf MN, Ehsan H, Ehsan S, Sagheer U, Chaudhary F. Glycogenic hepatopathy: a reversible complication of uncontrolled diabetes mellitus. Cureus 12: e9323, 2020.","DOI":"10.7759\/cureus.9323"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Maharaj V, Fitz M, Ding X. Drug-induced liver injury in the setting of glycogenic hepatopathy. J Gen Intern Med 32: 714-717, 2017.","DOI":"10.1007\/s11606-017-3996-z"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Alenazy LA, Javed M, Elsiesy H, Raddaoui E, Al-Hamoudi WK. Glycogenic hepatopathy: a rare hepatic complication of poorly controlled type 1 DM. Case Rep Med 2020: 1294074, 2020.","DOI":"10.1155\/2020\/1294074"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Imtiaz KE, Healy C, Sharif S, et al. Glycogenic hepatopathy in type 1 diabetes: an underrecognized condition. Diabetes Care 36: e6-e7, 2013.","DOI":"10.2337\/dc12-1134"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ahmed FW, Kirupakaran T, Quante M, Smith A. Hepatomegaly, elevated hepatic enzymes, and bridging fibrosis in patients with type 1 diabetes mellitus. Cureus 13: e14446, 2021.","DOI":"10.7759\/cureus.14446"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Azhar M, Hammami M, Musmar A, Bromer M. Glycogen hepatopathy: a reversible yet relapsing cause of hepatitis in type 1 diabetics. Cureus 13: e13441, 2020.","DOI":"10.7759\/cureus.13441"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Dolip W, Bourmanne E, Van Homwegen C, Van Nuffelen M. Persistent hyperlactatemia in decompensated type I diabetes with hepatic glycogenosis and hepatomegaly: mauriac syndrome: a case report. J Med Case Rep 16: 232, 2022.","DOI":"10.1186\/s13256-022-03416-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Murata F, Horie I, Ando T, et al. A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI. Endocr J 59: 669-676, 2012.","DOI":"10.1507\/endocrj.EJ12-0081"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Bak JCG, Sern\u00e9 EH, de Valk HW, et al. Gender gaps in type 1 diabetes care. Acta Diabetol 60: 425-434, 2023.","DOI":"10.1007\/s00592-022-02023-6"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/24\/63_3488-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T03:31:48Z","timestamp":1734751908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/24\/63_3488-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,15]]},"references-count":30,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3488-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,15]]},"article-number":"3488-24"}}